Pharmaceutical

US Senate committee interrogates big pharma on “outrageously high” drug prices

Pharma CEOs defended their high prescription drug costs, stating that the current prices are necessary for continued innovation.

Feb 10, 2024 - 18:00
US Senate committee interrogates big pharma on “outrageously high” drug prices
Pharma CEOs defended their high prescription drug costs, stating that the current prices are necessary for continued innovation.
Read the original article

Tags:

Previous Article

Hemogenyx gets reprieve as FDA lifts clinical hold on AML CAR-T therapy

Next Article

Vicore licenses idiopathic pulmonary fibrosis therapy to Nippon in Japan

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Covid-19: Anti-inflammatory drugs do not lead to a swif...

Jul 11, 2023

Valneva pushes FDA approval date for chikungunya vaccine

Valneva pushes FDA approval date for chikungunya vaccine

Aug 14, 2023

STAT+: FDA oncology head wants advisory panels to keep voting on new drugs

STAT+: FDA oncology head wants advisory panels to keep ...

Jun 6, 2023